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Abstract
Background: Since March 2020, COVID-19 has disproportionately impacted communities of color within the United
States. As schools have shifted from virtual to in-person learning, continual guidance is necessary to understand
appropriate interventions to prevent SARS-CoV-2 transmission. Weekly testing of students and staff for SARS-CoV-2
within K-12 school setting could provide an additional barrier to school-based transmission, especially within schools
unable to implement additional mitigation strategies and/or are in areas of high transmission. This study seeks to
understand the role that weekly SARS-CoV-2 testing could play in K-12 schools. In addition, through qualitative inter‑
views and listening sessions, this research hopes to understand community concerns and barriers regarding COVID19 testing, COVID-19 vaccine, and return to school during the COVID-19 pandemic.
Methods/design: Sixteen middle and high schools from five school districts have been randomized into one of
the following categories: (1) Weekly screening + symptomatic testing or (2) Symptomatic testing only. The primary
outcome for this study will be the average of the secondary attack rate of school-based transmission per case. Schoolbased transmission will also be assessed through qualitative contact interviews with positive contacts identified by
the school contact tracers. Lastly, new total numbers of weekly cases and contacts within a school-based quarantine
will provide guidance on transmission rates. Qualitative focus groups and interviews have been conducted to provide
additional understanding to the acceptance of the intervention and barriers faced by the community regarding SARSCoV-2 testing and vaccination.
Discussion: This study will provide greater understanding of the benefit that weekly screening testing can provide
in reducing SARS-CoV-2 transmission within K-12 schools. Close collaboration with community partners and school
districts will be necessary for the success of this and similar studies.

*Correspondence: sara.malone@wustl.edu
1
Department of Pediatrics, Washington University in St. Louis School
of Medicine, St. Louis, MO, USA
Full list of author information is available at the end of the article

© The Author(s) 2022, corrected publication 2022. Open Access This article is licensed under a Creative Commons Attribution 4.0
International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you
give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes
were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated
otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not
permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To
view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a
credit line to the data.

Hayes et al. BMC Public Health

(2022) 22:1177

Page 2 of 8

Trial Registration: NCT04875520. Registered May 6, 2021.
Keywords: COVID-19, SARS-CoV-2, Testing strategies, Underserved, Community, Public health, Cluster nonrandomized trial, Community-based participatory research, Under-resourced community

Background
The coronavirus disease 2019 (COVID-19) pandemic
has illuminated the disproportionate social and health
disparities present within US communities of color. The
elevated case rates, increased deaths associated severe
acute respiratory syndrome coronavirus-2 (SARSCoV-2) infection and decline in economic opportunities are just a few of the repercussions experienced
within these communities [1, 2]. For children, a return
to in-person learning has been met with hesitancy due
to the concerns of COVID-19 transmission that in-person learning could pose.
Evidence demonstrates that school-based transmission of SARS-CoV-2 is low in the presence of COVID19 mitigation strategies [3, 4]. Schools that have
effectively implemented interventions such as social
distancing, hand hygiene, masking, and increasing ventilation, have shown limited school-based transmission
[3–6]. The US Centers for Disease Control & Prevention (CDC) school guidelines promote weekly screening testing as an important preventative measure within
K-12 schools, especially when other prevention strategies are unable to be enacted and local transmission
rates are high [7]. There is limited research evaluating
the impact of weekly screening testing for SARS-CoV-2
within the K-12 school setting. There is also limited
data evaluating the testing and vaccine barriers faced
within predominant communities of color.
This study will assess whether weekly screening testing decreases SARS-CoV-2 transmission in middle and
high schools. Additionally, the school communities’

concerns regarding in-person learning, testing, and
vaccinations as it relates to the COVID-19 pandemic
will be assessed.

Methods
Study setting and population

Five school districts within the north part of St. Louis
County have been included. Students, school staff, and
their household members are eligible to participate in the
study. Sixteen middle and high schools from these school
districts are participating. In these districts, 50–99% are
comprised of minority communities and 18%-42% of
families live below the poverty line [8] (Table 1). Additionally, all schools in this study receive Title 1 funding and have 100% of their students receiving free and
reduced lunch. The percent of in-person attendance during the 2020–2021 school year was 20%-42%.
Study design

A cluster randomized trial is being conducted during
the 2021–2022 school year (Fig. 1). This design was
chosen due to the ease of ability to directly compare
interventions between schools and to mitigate allocation and selection bias within the participants. Sixteen middle and high schools within the five school
districts were randomized 1:1 into one of two interventions. The first intervention was available to all
schools within the 5 districts (including early learning centers and elementary schools) and consisted of
access to free symptomatic or exposure-based testing.
The second intervention was weekly screening based

Table 1 School Demographic Characteristics
District 1

District 2

District 3

District 4

District 5

# of Students/Staff (# of students in-person)
Middle School Students

800 (160)

420 (120)

600 (240)

2590 (905)

19 (1261)

Middle School Staff

44

40

75

270

213

High School Students

650

720 (300)

800

2900 (1015)

83 (1762)

High School Staff

54

65

100

325

256

Student Race/Ethnicity (%)
Black

95%

98%

83%

84%

35.1%

White

2%

1%

9%

6%

40.0%

Hispanic/Latinx

0%

0%

4%

3.5%

11.4%

Multi-racial

2%

1%

3%

4%

9.6&

$31,646

$37,361

$59,449

$49,209

$60,732

Median Household Income
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Fig. 1 Cluster randomized trial design being utilized to assess if weekly screening testing can further limit COVID-19 transmission

COVID-19 testing for the students, staff, and their
household members plus the ability to receive symptomatic or exposure testing when needed. Symptomatic
and exposure testing began in May of 2021 while the
duration of the weekly screening testing intervention
has been occurring during 2021–2022 school year.
A qualitative study is being conducted concurrently
with COVID-19 testing (described above) to provide
a deeper understanding of the community’s experiences and concerns about the pandemic, testing,
and vaccinations. Focus groups are being conducted
with students, parents/caregivers, and staff. School
administrators are participating in semi-structured
interviews.
This trial was registered to ClinicalTrials.gov on
May 6, 2021. The Washington University in St. Louis
School of Medicine institutional Review Board (IRB)
has approved this study (202,104,013). Any important
protocol changes will first be submitted to the IRB and
then will be disseminated appropriately to study participants, investigators, journals, and other stakeholders.

Community engagement
To better serve the communities of the study, we have
partnered with local federally qualified health centers
and community development and social service organizations. These organizations have been providing guidance regarding the best messaging and communication
strategies for study participation and barriers to testing
throughout the study. They have also aided us in recruitment for both testing and listening sessions and helped
testing referrals and convening listening sessions.

Community Advisory Board (CAB)

This project’s success relies on these community partnerships and our maintenance of trust with these school
communities. A Community Advisory Board (CAB)
has been developed to review study procedures to help
ensure our study is conducted appropriately. The CAB
has been fundamental in addressing the following issues:
barriers to testing, participant retention, communication with the community, beliefs and attitudes about
COVID-19, and other study-related activities. The CAB
has met monthly and is comprised of parents, students,
teachers, and administrators from each school districts
and representatives from the community partners assisting with the project. The CAB is facilitated by research
team members from the Brown School of Social Work
and Public Health and Washington University School of
Medicine testing team. This CAB will continue meeting
throughout the entire study.

COVID‑19 testing procedures
Recruitment

The community partners and CAB were consulted in
developing a variety of effective and appropriate recruitment strategies within the school and community. The
recruitment has been focused in two main areas. First,
within the schools such as back-to-school events, townhall meetings, classrooms, and staff meetings to increase
awareness about the study. Second, the study team has
been conducting a mixed-methods approach to raise
awareness about the study. Participating school districts disseminated study material to students, staff, and
parents through electronic platforms, email, and meetings. One community partner has helped promote the
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testing and focus groups through canvassing efforts that
consisted of door to door delivery of study promotional
materials in two school districts.
Testing

The Washington University saliva-based SARS-CoV-2
RT-PCR assay has been utilized in this study. This test,
developed in conjunction with Fluidigm received emergency use authorization approval in August of 2020 [9].
Testing is performed in a CLIA/CAP certified laboratory
and reported out through the Department of Pathology and Immunology at Washington University. The
saliva-based assay requires that participants provide
approximately 0.5 ml of saliva in a specified collection
vial to conduct the analysis and is available for all age
participants.
Screening testing

Eight of the sixteen schools have been randomized to
receive weekly screening testing for students, staff, and
their household members in addition to symptomatic
testing. The site location and times within the randomized schools were arranged with school administration to occur on a weekly basis. The saliva-based testing
method allows for staff, students, and their household
members to collect the sample at home or school, then
give it to a research team member on their designated
weekday for specimen collection. Weekly screening testing has been available whenever in-person school is provided for schools randomized to this strategy.
Prior to starting screening testing, students, staff, and
their household members were consented or assented
in-person (group or individual discussion), by phone,
or by zoom. Middle and high school students under the
age of 18 provided assent (if cognitively able) for participation after consent was obtained from their parent/
legally authorized representative (LAR.) Since household
members/parents/LARs were not present in the school,
they were able to receive a copy of the consent document
prior to the consent discussion.
Symptomatic testing

All schools, including early learning centers and elementary schools, in the five districts have access to saliva
SARS-CoV-2 polymerase chain reaction (PCR) testing
for students, staff, and household members who exhibit
symptoms of COVID-19 or have a known exposure. This
testing has been provided for both virtual and in-person
staff and students. Test samples have been collected at a
designated drive-up testing site approximately five days a
week. These drive-up testing sites rotate on a daily basis
in the five school districts. In situations where transportation have been limited, home visits have been offered.
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For eligible individuals who present to a nurse or study
team member in two of the school districts, they have
been informed about the testing option and if interested,
consented and tested at site. Study Team members then
collect samples within 24 h and transfer them to the
laboratory.
For those who were only seeking symptomatic and/
or exposure testing, verbal consent and assent (when
appropriate) were obtained prior to testing, in addition
to a copy of the consent information. Additionally, at
the time of first consent, individuals complete the necessary Health Insurance Portability and Accountability Act
(HIPAA) and email communication forms.
If a student is 18 to 21 years of age was not cognitively
able to provide consent/assent, consent was obtained
from the legally authorized representative. Children
8–17 years of age who were developmentally able will
provide assent. Children age 5–7 would not be providing
assent due to their age and development. The consenting/
assenting process would be done virtually, in person or
by phone.
Sample collection and processing

At the testing site(s), 0.5 ml of saliva are collected from
each subject under the supervision of a trained research
team member. Study team members then label and process the specimen through a Research Electronic Data
Capture (REDCap) database. A study team member
transports the specimen to the laboratory for processing. Negative test results are automatically sent to participants within 24–48 h of processing. For positive test
results, a physician (JGN, SF) affiliated with the study
calls the participant to inform them of their result prior
to sending them their test report. The physicians can
address questions of the participants and inform them of
any potential therapies that might be indicated.

Data
In addition to the saliva testing data, we have been
obtaining surveys from the following: (1) school districts,
(2) participants who performed saliva testing, and (3) eligible COVID-19 positive cases and their close contacts.
School level data

To understand the current mitigation strategies present
at each school, schools have been asked to complete a
school-based mitigation strategy survey. This survey,
developed in conjunction with the CDC and utilized in
prior school-based investigations, included the following questions: method of instruction (e.g., hybrid, type of
hybrid, fully in-person) and date implemented, masking
recommendations and perceived compliance, distancing
in classrooms, use of physical barriers (e.g., Plexiglas),
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location and processes for eating lunch, and mitigation
strategies used in extracurricular activities (e.g., sports,
choir, band) [5]. Any alterations to a school’s mitigation
plan have been documented and will be taken into consideration during data analysis and interpretation. To
understand transmission rates, schools were also asked
about their quarantine rates and new school-based cases/
contacts on a weekly basis.
Participant level data
Testing

All individuals are asked one-time basic demographic
and contact information that is needed to meet state
requirements. The following information is collected
from every participant during every sample collection: presence of symptoms, list of symptoms present
in the past week and start date (if applicable), and date
of sample collection. For individuals receiving symptomatic or exposure testing, the following additional
information is obtained for each test collection: purpose for testing, their affiliation with the school (Student, Staff, or household member of student or staff ),
affiliated school district, and vaccination status. Test
results are saved for each visit.
Case and contact interviews

If any of these individuals or other students/staff present
in the school setting are positive for COVID-19, contact
tracing has been performed by their school districts per
local guidance. As part of their contact tracing, individuals have been informed that that they may be contacted
by a member of the study team to see if they would like
to provide additional information via participating in
this study. Our research team has been contacting any
cases and their known contacts in the school setting, as
provided by the schools. After consent and assent (for
those 8–17) is obtained, we asked a series of contact tracing questions about their behaviors and potential exposures. A separate case interview has also been conducted
for any known contacts that have a subsequent positive
COVID-19 test.
Common data elements survey

Anyone who has consented for screening testing, has a
symptomatic testing performed for the purpose of this
study and/or was identified during contact tracing, will
be asked to complete the tier one common data elements
(CDE) survey developed by the National Institutes of
Health (NIH) [10]. Once consents have been obtained via
phone, Zoom, email or in person, a link to a survey with
the questions has been sent. All data collection forms are
available from the research team.
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Focus Groups and Interviews
The main objectives of the focus groups and interviews
is to understand the social, behavioral, and ethical factors influencing participants’ decisions and perceptions
about: 1) the impact of COVID-19 on schooling; 2) facilitators and barriers to testing, attending in-person school,
and vaccination; 3) successes and challenges experienced
by school leadership regarding the return to in-person
learning; and 4) the resources and supports provided. Eligible individuals consist of administrators, students, staff,
and parents/caregivers in all five-school districts. Facilitation guides were developed for each target population
and were reviewed by the CAB.
The participating school districts have shared a project description through multiple methods (e.g., email,
electronic platforms, meetings) with parents/caregivers,
school staff, and administrators to raise awareness about
the study and participant recruitment. Recruitment also
occurred at back-to-school events for families and students and during staff professional development trainings. Recruitment flyers with a (quick response) QR code
have been disseminated. The QR code directs potential
participants to a Qualtrics survey to sign up for a focus
groups, along with demographic information. For the
school administrator interviews, team members have
shared project description directly with the administrators via email that includes a signup link.
Prior to the focus groups, interested participants have
been emailed a consent information sheet. We have
obtained verbal consent from the participants at the
beginning of sessions in addition to providing a copy of
the information sheet.
The majority of qualitative data collection occurs virtually via Zoom with a few student sessions being conducted in-person [11]. Each session is scheduled for one
hour. All sessions are conducted by a trained facilitator and note taker on the study team. The sessions are
recorded and transcribed. A directed thematic content
analysis is being conducted using NVivo v12 [12, 13].
Data Management
The participant’s information is protected throughout all
aspects of data entry, coding, storage, and disseminated
within secure, password-protected REDCap database and
paper copies. Safeguards are in place to ensure data quality and participant’s confidentiality (E.g. restricted access,
hot spots, warnings of missing responses, data quality
reports.) For students and staff who complete informed
consent, their positive results may be shared with the relevant school, after the individual has been called, notified
of their positive result, and provides verbal re-confirmation of their permission to share that information.
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Consent is obtained from participants for future use of
biospecimens (saliva). The consent form allows participants to opt-out of having their saliva specimens stored
and being contacted for future research studies including
COVID-19 vaccination trials in children.
Our existing Consortium Data Reporting Unit (CDRU),
in collaboration with our data manager, coordinate the
submission of CDEs on COVID-19 testing-related outcomes to the Central Data Coordinating Center affiliated
at Duke University and ensure compliance with federal,
state, and local requirements for testing. We will comply
with data sharing as mandated by the NIH and follow
guidance provided by the CDCC for data management
and support.
Important to this study is the monitoring of the social,
ethical, and equity implications associated with the testing implementation in these underserved communities. All participants have been given the opportunity to
express their concerns and identify barriers to participating in the study at time of enrollment. Additionally,
a study email and phone number have been available for
participants to provide feedback and voice any concerns
about the project. Additionally, any concerns with the
study will be reviewed by the team and reported to the
institutional research office.

from the case interview, contact interview, and contact
tracing interview to determine whether a school-based
transmission has occurred. These transmission events
will be classified into the following categories with standardized definitions that were developed in conjunction
with the CDC: probable, possible, unlikely, and unable to
determine.
The second method to evaluate school-based transmission is to utilize collected weekly data from the schools,
as participation in the above individual assessments is
unlikely to reach 100%. The additional data collected will
include total number of new staff and student cases, total
number of new contacts, and number of school-based
contacts that become new cases during their quarantine
period. The secondary transmission rate will be calculated based on the number of positive school-based contacts per positive case. This method will provide the most
conservative/greatest estimate of school-based transmission without knowledge of an individual’s exposure to a
potential household or community case.
Lastly, if contacts are not collected are we are not able
to obtain from the school, we will utilize the weekly case
rates at each school. All schools have been able to provide this information.

Outcomes

Power calculation

The primary outcome is the secondary attack, defined as
the ratio of the number of infected contacts to the total
number of contacts for an infected participant. It is either
NA or 0 for a participant without an infection. Such a
definition is at the participant-level and its value is NA,
(0–1). If we are unable to reliably obtain this information
due to rule changes in quarantining or the lack of case
and contact investigations, we will utilize the student and
staff case rates collected by the school.
School-based transmission will be determined by two
methods. First, all close contacts of an infectious case in
the school, identified through contact tracing by school
staff and administrators, have been approached to participate in the study (as described above). Those electing to participate have undergone a contact interview to
understand their behaviors and potential other COVID19 exposures. Furthermore, the school contact tracer has
completed a survey on the relationship of the case to each
contact that provides information on the location of the
exposure (e.g., classroom, lunch, extracurricular activity), distance between case and contact, use of barriers,
masking adherence, and total amount of time the contact
was exposed to the case. The contacts will be offered testing 5–7 days after a school exposure. All contacts testing positive have undergone an independent review by
five study team members using the information obtained

A cluster randomized trial (CRT) will be conducted at 16
schools that provide symptomatic SARS-CoV-2 testing to
students and staff from 2021–2022 school year. Schools
are randomized 1:1 to either screening testing plus symptomatic testing, or symptomatic testing only. All participants including students and staff received the same
assignment within a given school. The primary outcome
is transmission rate, defined as the ratio of the number of
contacts testing positive for SARS-CoV-2 to total number
of contacts for each school-based case. We hypothesize
that schools performing screening testing will have lower
transmission rates than routine symptomatic testing. We
expect that transmission rates with screening testing or
routine symptomatic testing will be 2% and 8%, respectively. With the assumptions that the intracluster correlation coefficient (ICC) is 0.02 and the standard deviation
of transmission rate is 0.22, 8 schools in each arm with
an average of 117 participants per school will achieve
80% power to detect a difference in transmission rates
between the two study arms using a two-sided t-test at a
significance level of 0.05 (Table 2). PASS 15.0 was used to
conduct this power analysis.

Statistical analysis plan

Analysis plan

The generalized estimating equation (GEE) model with
appropriate link function (e.g., identity for primary
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Table 2 Power Calculation
8 schools per group
ICC

Standard deviation

# of
participant
per school

0.01

0.25

52

0.30

96

0.33

145

0.02

0.35

199

0.22

55

0.23

67

0.24

83

0.25

105

0.03

0.20

62

0.21

84

0.04

0.18

58

0.19

89

0.05

0.16

44

0.17

71

outcome) will be used to analyze the CRT data, in which
the correlation among participants within each school
needs to be considered. The autoregressive of first order
as a working correlation structure will be used, and participants with missing values will be excluded from the
GEE analysis. The GEE model includes the group indicator and other potential factors, including race/ethnicity, insurance status, age, gender, underlying diagnoses,
masking, distancing, ventilation, location of transmission. Least square means for the primary outcome per
group will be estimated, and the standard errors will
be calculated with the GEE sandwich method when
accounting for within-school correlation. All analyses
will be conducted using Statistical Analysis System (SAS)
(SAS Institute, Cary, NC) at the two-sided significance
level of 0.05.
This work will be disseminated using multiple strategies. This will include academic publications as well as
reporting out to registries, stakeholder groups, and funding agencies. Additionally, the study team will present the
information to the community stakeholders and community members engaged in the research.

Discussions
This research seeks to evaluate how effective weekly
SARS-CoV-2 testing would be as a school-based mitigation strategy in preventing school-based SARS-CoV-2
transmission. The two methods, (1) screening testing + symptomatic testing and (2) symptomatic testing
alone, will be compared to understand the intervention’s
possible success. We believe that screening testing will

cause an additional barrier against case transmission and
will result in lower case rates within the implemented
schools.
Weekly testing is a prevention measure against transmission that has only recently become implemented
within private and public K-12 school settings in the
US. Conducting and studying the efficacy weekly testing within K-12 schools is a unique opportunity that can
be tremendously beneficial to public health guidance.
Following close guidance to good clinical practices, in
addition to the support of the affiliated schools and local
communities, is crucial to the success of this and similar
community-based research projects. Our testing intervention, coupled with qualitative focus groups and interviews, is well-suited to understand the efficacy of weekly
SARS-CoV-2 testing in school settings, acceptance
of proposed intervention, and public reception to the
SARS-CoV-2 pandemic and public health involvement.
We understand that this study has several limitations
that could impede its success. First, weekly testing operations depend on the in-person learning and participant’s
interests within the randomized schools. Return to
remote learning due to significant increases in COVID19 transmission could result in a sudden drop of weekly
testing samples. Additional schools may be identified
and selected to participate if schools remain remote, or if
testing volumes are lower than expected.
Abbreviations
CAB: Community Advisory Board; CDC: US Centers for Disease Control &
Prevention; CDE: Common Data Elements; CDRU: Consortium Data Reporting
Unit; CRT: Cluster randomized trial; COVID-19: Coronavirus disease 2019; GEE:
Generalized estimating equation; HIPPA: Health Insurance Portability and
Accountability Act; ICC: Intracluster correlation coefficient; LAR: Legally author‑
ized representative; NIH: National Institutes of Health; QR: Quick response;
PCR: Polymerase chain reaction; REDCap: Research Electronic Data Capture;
SAS: Statistical Analysis System; SARS-CoV: Severe acute respiratory syndrome
coronavirus 2; WashU: Washington University in St. Louis.
Acknowledgements
We would like to acknowledge the contributions of Cindy Terrill, McDonnel
Genome Institute, Tejas Sekhar, Humza Agha, Lily Simeon, Brian Bangs, Robert
Darby, Nidhi Shinde, Naitra Ramchander, Anika Varski, Ana Torres, Hannah
Frey, Nicolas Barksdale, Erika Schneider-Smith, Mason Basler,  Luke Roven‑
stine, Malar Muthukumar. This work would not have been possible without
their support.
Authors’ contributions
SH drafted the manuscript and contributed to the logistical framework of
the study. SM contributed to the development and design of the study, data
collection tools, IRB approval and continual modifications, and continued
quality assurance. SM substantially participated in the drafting protocol and
data management. BB contributed to the development and design of the
study, data collection, and the maintenance of community partnership. BM
helped in solidifying partnerships with the school districts, aided in study
design, and data collection. BM participated in drafting the manuscript. NM
and KH contributed to the Study design and drafting of the manuscript. SAR,
SMR, JP, and JS aided in acquisition of data. In addition to data collection, CE
contributed to engaging community partners and maintaining these relation‑
ships. TW contributed to data management and analysis, in addition to data

Hayes et al. BMC Public Health

(2022) 22:1177

collection. SA and GY helped in data collection with a heavy focus in the con‑
tract tracing data. ND contributed to the drafting of the manuscript and data
analysis. EL participated in the study design and provided expertise on study
outcomes and data analysis plan. El participated in drafting the manuscript.
AL and IL provided expertise in Informatics and data management. SF aided in
designing the trial and drafting the manuscript. JS helped design the clinical
trial, identify partnerships and school districts, and drafted and revised the
manuscript. All authors reviewed and approved of a final draft.
Funding
This study was funded by the National Institute of Child Health and Human
Development (NICHD). The views and statements of this article are those
solely of the authors and are not reflective of the NICHD.
Availability of data and materials
Not applicable.

Declarations
Ethics approval and consent to participate
This study was approved by Washington University in St. Louis, IRB
#202104013. Consent will be obtained from all participants in the study.
Due to the nature of some of the symptomatic testing procedures, there
are certain instances where verbal consent or a waiver of documentation is
approved by the IRB. Written consent will be obtained either through wet ink
or electronic signature procedures.

Page 8 of 8

6.
7.

8.
9.
10.
11.
12.
13.

Hershow RB, Wu K, Lewis NM, et al. Low SARS-CoV-2 Transmission in
Elementary Schools - Salt Lake County, Utah, December 3, 2020-January
31, 2021. MMWR Morb Mortal Wkly Rep. 2021;70(12):442–8.
Centers for Disease Control and Prevention. Schools and Child Care
Programs: Plan, Prepare, and Respond. 2021; https://www.cdc.gov/coron
avirus/2019-ncov/community/schoolschildcare/ index.html. Accessed 11
Mar 2021.
NCES; 2022; https://nces.ed.gov/. Accessed 17 Apr 2022.
Fluidigm; Advanta Dx SARS-CoV-2 RT-PCR Assay. 2021; https://www.fda.
gov/media/141541/download. Accessed 17 Apr 2022.
RADx-UP; NIH Radx-up Common Data Elements. 2022; https://radx-up.
org/learning-resources/cdes/#files. Accessed 17 Mar 2022.
Zoom. Security Guide. Zoom Video Communications, Inc.; 2021:1–9.
https://explore.zoom.us/docs/doc/Zoom-Security-White-Paper.pdf.
Accessed 4 Apr 2022.
Hsieh HF, Shannon SE. Three approaches to qualitative content analysis.
Qual Health Res. 2005;15(9):1277–88.
QSR International Pty Ltd. (2020) NVivo (released in March 2020), https://
www.qsrinternational.com/nvivo-qualitative-data-analysis-software/
home

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in pub‑
lished maps and institutional affiliations.

Consent for publication
Not applicable.
Competing interests
Dr. Jason Newland reports funding from the National Institute of Health. All
other authors declare that they have no competing interests.
Author details
1
Department of Pediatrics, Washington University in St. Louis School
of Medicine, St. Louis, MO, USA. 2 Brown School, Washington University in St.
Louis, St. Louis, MO, USA. 3 Department of Occupational Therapy, Washington
University in St. Louis School of Medicine, St. Louis, MO, USA. 4 Department
of Surgery, Washington University in St. Louis School of Medicine, St. Louis,
MO, USA. 5 Department of Medicine, Washington University in St. Louis School
of Medicine, St. Louis, MO, USA. 6 Department of Pathology and Immunology,
Washington University in St. Louis School of Medicine, St. Louis, MO, USA.
Received: 13 May 2022 Accepted: 2 June 2022

References
1. Van Dyke ME, Mendoza MCB, Li W, et al. Racial and Ethnic Disparities in
COVID-19 Incidence by Age, Sex, and Period Among Persons Aged <25
Years — 16 U.S. Jurisdictions, January 1–December 31, 2020. MMWR
Morb Mortal Wkly Rep. 2021;70 (11);382–8.
2. Johnson A, Buford T. Early Data Shows African Americans Have Con‑
tracted and Died of Coronavirus at an Alarming Rate. Propublica. 2020.
https://www.propublica.org/article/early-datashows- african-americanshave-contracted-and-died-of-coronavirus-at-an-alarming-rate. Accessed
11 Mar 2021.
3. Zimmerman KO, Akinboyo IC, Brookhart MA, et al. Incidence and
Secondary Transmission of SARS-CoV-2 Infections in Schools. Pediatrics.
2021;147(4):e2020048090
4. Falk A, Benda A, Falk P, Steffen S, Wallace Z, Hoeg TB. COVID-19 Cases
and Transmission in 17 K-12 Schools - Wood County, Wisconsin, August
31-November 29, 2020. MMWR Morb Mortal Wkly Rep. 2021;70(4):136–40.
5. Dawson P, Worrell MC, Malone S, et al. Pilot Investigation of SARS-CoV-2
secondary transmission in kindergarten through grade 12 schools
implementing mitigation strategies – St Louis County and City of
Springfield, Missouri, December 2020. MMWR Morb Mortal Wkly Rep.
2021;70(12):449–55.

Ready to submit your research ? Choose BMC and benefit from:

• fast, convenient online submission
• thorough peer review by experienced researchers in your field
• rapid publication on acceptance
• support for research data, including large and complex data types
• gold Open Access which fosters wider collaboration and increased citations
• maximum visibility for your research: over 100M website views per year
At BMC, research is always in progress.
Learn more biomedcentral.com/submissions

